ab
UBS Asset Management
                                                                                                    Hong Kong edition | End August 2020
Grow with
future leaders
in China
UBS (Lux) Equity Fund –                                                                                         yuan jian | foresight, vision
China Opportunity (USD)
Morningstar Rating™
       As at 31-8-2020
                                                       Awards in Hong Kong
                             Fund Selector Asia Awards 2020                                Benchmark Fund of the Year Awards 2019
                             Platinum award of Greater China/                              Best-in-Class of China Equity category
                             China Equity category
                                                                                           Refinitiv Lipper Fund Award 2020
                                                                                           Best Fund over 3 years, Equity China
                                                                                           Best Fund over 5 years, Equity China
                             Morningstar Awards 2020
                             Best Greater China Equity Fund
  Important information
  1. The Fund, UBS (Lux) Equity Fund – China Opportunity (USD) (“UBS China Opportunity Equity Fund”) primarily invests in
     shares of companies that are either domiciled in or with their main business in China. The aggregate exposure (whether direct or
     indirect) to China A-Share and China B-Share markets for the Sub-Fund will be maintained at 20% or below of its total net asset value.
  2. The Fund’s investments in emerging markets, e.g. PRC, may involve a greater risk than developed markets including sharp price
     movements, liquidity risk and currency risk. The Fund’s investment in a single country may be subject to a higher level of risks
     comparing to a fund investing in a more diversifed portfolio/strategy. Under extreme market circumstances, the Fund may suffer
     substantial loss.
  3. The Fund may use fnancial derivative instruments (“FDI”) for investment management and hedging purposes. Although fnancial
     derivative instruments will not be used extensively for investment purposes, the use of derivatives may involve additional risks, e.g.
     leverage, liquidity, counterparty risks.
  4. Specifcally for the P-mdist share class, the Fund may at the discretion of the Management Company make distributions out of
     capital or out of gross income while charging/paying all or part of the Fund’s fees and expenses to/out of capital of the Fund,
     resulting in an increase in the payment of dividends by the Fund. Payment of dividends out of capital or on a gross-of-fee basis may
     result in an immediate reduction of the net asset value per share.
  5. Any distributions from the income and/or involving the Capital result in an immediate reduction of the net asset value per unit of
     the fund. Payment of dividends out of Capital amounts to a return or withdrawal of part of an investor’s original investment or from
     any capital gains attributable to that original investment.
  6. Investors should not invest in the Fund solely based on this document and should read the relevant offering document.
Why invest in China Equity Market?
China is transforming its economy and creating opportunities
China will go through signifcant transformation that will reshape the economy, cement China’s position in the world
and create a wealth of opportunities for investors.
60%
                                                                                                                                                                       Services
50%                                                                                                                                                                    Sector
                                                                                                                                                                       overtakes
40%
                                                                                                                                                                       Manufacturing Sector
30%
20%
10%
                                                                                                                                                                       Agriculture Sector
 0%
      2003    2004   2005     2006    2007     2008       2009   2010   2011   2012   2013        2014          2015       2016     H1 2017
 Key fundamental strategies                                                                                                                     Impact
                      Services and consumer-led growth:                                                                                         Reforms and growing
                      where services account for 56%1 of total GDP and                                                                          consumer demand are
                      consumer demand overtakes investment as the principal                                                                     supporting the emergence
                      driver of the economy.                                                                                                    of the services sector
Source: National Bureau of Statistics, China GDP sectoral breakdown, data period 2003 – H1 2017.
New economy sectors take the lead
Increasing demands on Healthcare services when                                         China’s internet sector has much more room for growth
ageing population rapidly increases
China’s expenditure in private healthcare is growing at high speed                     Mobile internet dominates the online shopping market
                                                                                       Online spending on                                                                         Alibaba’s share of
                                                                                       a single day                                                                                    mobile sales
                                                                                       USD (bn)
                                                                                       30                                                                                                    100%
                                                                                                                                                                                              90%
             US             France           Germany             China                 25                                                                                                     80%
                                                                                                                                                                                              70%
             3.8%            3.7%             3.8%               16.4%                 20
                                                                                                                                                                                              60%
                                                                                       15                                                                                                     50%
                                                                                                                                                                                              40%
                                                                                       10                                                                                                     30%
                                      UK           Japan                                                                                                                                      20%
                                                                                        5
                                     1.7%           1.2%                                                                                                                                      10%
                                                                                        0                                                                                                      0%
                                                                                                    2013                  2014             2015                2016              2017
                                                                                            Black Friday (US)          Cyber Monday (US)      Alibaba Singles Day (China)     Share of mobile sales
•     Increasing private expenditure on health services is creating                    •      Chinese consumers spending more time on mobile internet
      a new breed of leading industry companies in the health                                 and internet users are spending more online through the
      sector                                                                                  innovative mobile-based apps
•     Healthcare spending as of % of GDP in China is only 3-7%                         •      China’s internet user base is the largest in the world, yet
      and trails that of Japan, Australia, Europe and US (9-17%)2                             penetration rates (53.2% in 2016) lag behind developed
                                                                                              markets3
Source: World Health Organization: Global Health Expenditure Database, average         Source: Statista, 2018.
growth rate in 2005-2014.
1 China NDRC (National Development and Reform Council).
2 OECD data, 2014.
3 Internet Live Stats: Internet Users by Country, 2016.
Why invest in UBS China Opportunity Equity Fund?
Outstanding performance
5 years performance (rebased to 100)
                                                                                                                                                                              Performance                   Fund            Reference Peer Average:
400                                                                                                                                                                           (in USD, %)                cumulative        Index: MSCI China Equity
                                                                                                                                                                              (net of fees)                returns         China 10/40
350
                                                                                                                                                                              YTD4                         23.49                  16.27             22.61
300
                                                                                                                                                                              1 Year                       38.38                  32.76             36.87
250
                                                                                                                                                                              3 Years                      66.95                  26.27             34.30
200
                                                                                                                                                                              5 Years                      164.99                 84.16             85.57
150                                                                                                                                                                           Source: UBS Asset Management, Morningstar, Bloomberg, data as of 31 August
                                                                                                                                                                              2020, unless otherwise stated. UBS (Lux) Equity Fund – China Opportunity (USD)
                                                                                                                                                                              fund inception: 15 November 1996. Repositioned to current strategy on 19 July
100                                                                                                                                                                           2010. Performance is calculated on NAV to NAV basis, with dividend reinvested,
                                                                                                                                                                              based on P-acc (USD). Performance shown is net of fees. Annual performance of
                                                                                                                                                                              UBS (Lux) Equity Fund – China Opportunity (USD) P-acc in the last f ve years: 2015
                                                                                                                                                                              (+16.0%), 2016 (-2.3%), 2017 (+59.7%), 2018 (-14.8%) and 2019(+41.6%). Past
    50
                                                                                                                                                                              performance is not indicative of future results. Reference index changed from
                                                                                                                                                                              MSCI China to MSCI China 10/40 with effect from 1 January 2018. Peer Group
                                                                                                                                                                              average is the average fund performance of Morningstar China Equity universe (in
   0                                                                                                                                                                          terms of USD).
 Jul-10                                 Jan-13                               Aug-15                                      Feb-18                                    Aug-20
          UBS China Opportunity Equity fund                                                   Reference Index                                       Peer Average              4 YTD: Year-to-date (since beginning of the year)
New economy sectors at the heart of the fund portfolio
Sector allocation                                                                                                                                                                 Top 10 holdings                                    Fund (%)       Index (%)
35.0%                                                                                                                                                                             Alibaba                                                 9.95         9.55
30.0%
                                                                                                                                                                                  Tencent Holdings Ltd                                    9.61         8.09
25.0%
20.0%                                                                                                                                                                             TAL Education Group                                     9.24         1.30
15.0%                                                                                                                                                                             Ping An Insurance                                       6.31         3.26
10.0%                                                                                                                                                                             Kweichow Moutai                                         5.01         0.91
 5.0%
                                                                                                                                                                                  Yihai International Holding                             4.77         0.34
 0.0%
              Consumer
           Discretionary
                           Financials
                                          Cash
                                                 Communication
                                                      Services
                                                                 Consumer
                                                                   Staples
                                                                               Health Care
                                                                                             Real Estate
                                                                                                           Industrials
                                                                                                                          Information
                                                                                                                          Technology
                                                                                                                                        Utilities
                                                                                                                                                       Materials
                                                                                                                                                                     Energy
                                                                                                                                                                                  Netease Inc                                             4.61         1.83
                                                                                                                                                                                  Hong Kong Exchanges & Clearing                          3.54            -
                                                                                                                                                                                  New Oriental Edu & Tech Grp                             2.66         0.96
                    UBS China Opportunity Equity Fund                                                      MSCI China 10/40 Index                                                 CSPC Pharmaceutical Group Ltd                           2.66         0.57
Source: UBS Asset Management. MSCI, Corporate information. Data as of 31 August 2020.
This information should not be considered as recommendation to buy or sell any security.
Invest in up and coming industry future leaders
                                                    TAL Education Group                                                                                                                                    Livzon Pharmaceutical
•        One of the leading after-school tutoring services provider                                                                                                           •     A mid-cap biopharmaceutical with leading drug innovation
         in China                                                                                                                                                                   culture
•        Actively developed its online education market, owning the                                                                                                           •     Livzon is estimated to be one of the biggest investors in
         top-notch online teaching platform                                                                                                                                         Products R&D in China’s healthcare sector
•        Small class offerings and online channels are a hit with                                                                                                             •     Newly developed products include anti-ulcer, fertility and
         Chinese students and parents                                                                                                                                               anti-cancer drugs
•        TAL offers exposure to increasing demand for tailored                                                                                                                •     Fertility drug is estimated to see a sales growth of 31%5
         education services in China, where there is good prospects                                                                                                                 between 2017 and 2019
         for long-term growth
                                                                                                                                                                              5 Source: UBS Investment Bank, 2017.
      Fund information
      Fund name                                                  UBS (Lux) Equity Fund – China Opportunity (USD)
      Fund inception date                                        15 November 1996
                                                                 (Repositioned to current strategy on 19 July 2010. Old sub-fund name
                                                                 was UBS (Lux) Equity Fund – Hong Kong)
      Base currency                                              USD
      Reference index                                            MSCI China 10/40
      Net asset value                                            USD 13.12 billion (as of 31 August 2020)
      Management fee                                             1.87% p.a. ; hedged share class: 1.91% p.a.
      Dealing                                                    Daily
      Available share classes                                    ISIN                                                               Subscription Fee
      (USD) P-acc                                                LU0067412154
      (HKD) P-acc                                                LU1008478684                                                             Up to 5%
      (AUD hedged) P-acc                                         LU1227825731
      (USD) P-mdist*                                             LU1152091168
      (HKD) P-mdist*                                             LU1152091754                                                            Up to 5%1
      (AUD hedged) P-mdist*                                      LU1230129766
* The share classes with ”-mdist” aim to pay dividends on a monthly basis. Dividend is not guaranteed. Dividend may be paid out of capital.
1 Hong Kong distributors will currently only charge up to 5% of the subscription amount. However, investors should note that a maximum of up to 6% of the subscription
  amount may be charged upon giving 1 month’s prior notice to affected investors.
2 Following the realignment of the UBS investment fund range, asset allocation for this fund was adjusted with effect from 19 July 2010. All performance details thus refer
  to the date of the repositioning.
3 Share classes with “-mdist” in their name may make monthly distributions excluding fees and expenses. They may also make distributions out of capital and realized
  capital gains, at the discretion of the Management Company, or pay distributions out of gross income while charging/paying all or part of a Subfund’s fees and expenses
  to/out of the capital of the relevant Subfund, resulting in an increase in distributable income for the payment of distributions by the Subfund and therefore, the Subfund
  may effectively pay distributions out of capital. Any distributions involving payment of dividends out of the fund’s capital or payment of dividends effectively out of the
  fund’s capital (as the case may be) may result in an immediate reduction of the next asset value per share/unit.
4 A positive distribution yield does not imply a positive return. The share classes with “-mdist” and “-dist” aim to pay dividends on a monthly basis and annual basis
  respectively. Dividend rate is not guaranteed. Distribution yield = (Dividend per unit on last record date x 12/Record Date NAV) x 100. The distribution yields shown here
  are for reference only.
Follow us on WeChat and LinkedIn for more insights
 WeChat                                                        LinkedIn
Visit www.ubs.com/chinaforesight
Investment involves risks. Past performance is not indicative of future performance. Investors should read the relevant offering document for details including the product
features and risk factors, in particular those associated with investments in emerging markets and fnancial derivatives instruments. The value of the funds and income from
them can go up as well as down and consequently you may not get back the amount originally invested.
This document has not been reviewed by the Securities and Futures Commission in Hong Kong. This document is issued by UBS Asset Management (Hong Kong) Limited. A
number of comments in this document are based on current expectations and are considered “forward-looking statements”. Actual future results may prove to be different
from expectations and any unforeseen risk or event may arise in the future. The opinions expressed are a refection of UBS Asset Management’s judgment at the time this
document is compiled and any obligation to update or alter forward-looking statements as a result of new information, future events, or otherwise is disclaimed.
You are advised to exercise caution in relation to this document. The information in this document does not constitute advice and does not take into consideration your
investment objectives, legal, fnancial or tax situation or particular needs in any other respect. Investors should be aware that past performance of investment is not necessarily
indicative of future performance. Potential for proft is accompanied by possibility of loss. If you are in any doubt about any of the contents of this document, you should
obtain independent professional advice.
Source for all data and charts (if not indicated otherwise): UBS Asset Management. © Copyright UBS 2020. The key symbol and UBS are among the registered and
unregistered trademarks of UBS. All rights reserved.
ab